GB Patent

GB2465099B — Capsule for use with a powder delivery device

Assigned to Optinose AS · Expires 2010-06-16 · 16y expired

What this patent protects

Patent listed against sumatriptan-succinate.

Drugs covered by this patent

sumatriptan-succinate (SUMATRIPTAN SUCCINATE)

Patent Metadata

Patent number: GB2465099B
Jurisdiction: GB
Classification: —
Expires: 2010-06-16
Drug substance claim: No
Drug product claim: No
Assignee: Optinose AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.